Ir al contenido
Grupo-Farma-del-Ecuador-Footer
  • Home
  • About Us
    • History
    • The Company
    • Join the Team
    • Corporate governance
      • Committees
      • Human rights
      • Code of ethics
      • Speak Up – complaints channel
      • Risk management
      • Global policies
  • Our Products
    • Cardiovascular Line
    • Gastrointestinal Line
    • Gynecological Line
    • Iron Line
    • Supplements and Vitamins Line
    • Urological Line
    • Other Products
  • Patients
    • Pharmacovigilance
    • Products Guide
    • Frequent Questions
  • Healthcare Professionals
    • Product Guide
  • Contact Us
    • Grupo Farma
    • Venezuela
    • Colombia
    • Perú
  • ES
  • Home
  • About Us
    • History
    • The Company
    • Join the Team
    • Corporate governance
      • Committees
      • Human rights
      • Code of ethics
      • Speak Up – complaints channel
      • Risk management
      • Global policies
  • Our Products
    • Cardiovascular Line
    • Gastrointestinal Line
    • Gynecological Line
    • Iron Line
    • Supplements and Vitamins Line
    • Urological Line
    • Other Products
  • Patients
    • Pharmacovigilance
    • Products Guide
    • Frequent Questions
  • Healthcare Professionals
    • Product Guide
  • Contact Us
    • Grupo Farma
    • Venezuela
    • Colombia
    • Perú
  • ES
Grupo-Farma-del-Ecuador-Footer

GASTROINTESTINAL

Milpax NF® | GrupoFarma del Ecuador

    Composition
    Each 10 ml sachet contains:

  • Sodium Alginate………..500mg
  • Sodium Bicarbonate …..267mg
  • Calcium Carbonate …… 160 mg

    Presentations

  • Box x 12 sachets of 10 ml each, cherry flavor.

    Indications

  • It is indicated for the coadjuvant treatment of gastroesophageal reflux, gastric hyperacidity and flatulence.

    Posology and Administration

  • 1-2 Sachets after each meal.

    Warnings

  • Precautions: As with other antacids, control should be maintained in patients on low sodium diets. At suggested doses, MILPAX® provides less than 1.5% of the 2400 mg of sodium recommended in a normal adult diet.
  • Precautions or restrictions of use during pregnancy and lactation: There are no known adverse events when this drug is used in pregnant or lactating mothers, however, it should be administered in these patients under medical supervision and taking into account the risk-benefit ratio for the patient.
  • No effects on fertility, mutagenesis and teratogenesis have been described.

    Interaction with other drugs

  • Antacids may affect the action of other drugs. To reduce this effect, MILPAX® should be administered two hours apart from other drugs.

Others Products

Cultiflor®

Leer más

Pridot®

Leer más

Vonau®

Leer más

Stamyl®

Leer más

Senokot®

Leer más

Oralyte®

Leer más

Normix®

Leer más

Neolax®

Leer más

Hepalive®

Leer más

Colypan®

Leer más
cropped-Grupo-Farma-del-Ecuador-Fav.png

Taking care of you very closely

Navigation

Home

News

Products

Frequent questions
 Work with us

Pharmacovigilance

Our Allies

Vidamine

Our Global Sites

Venezuela

Colombia

Peru

Grupo Farma

Contact

Edificio La Previsora, Torre A
Oficina 902
Quito, Ecuador

(+593) 23819760

informacion.ecuador@gfe.com.ec

Lunes a Viernes
8:00 a.m a 5:00 p.m
The information provided on this website was prepared by GrupoFarma S.A. and directed exclusively to medical personnel and health professionals. It may NOT be considered general use for people, nor as medical advice, recommendations or medical advice of any kind. We suggest not to self-medicate and consult your doctor beforehand about any concerns related to the information on the products or drugs mentioned here. Laboratories Farma S.A. will not be responsible for the misuse that third parties may give to the information obtained here.

© All rights reserved. 2023. Grupo Farma S.A. RIF J-00013393-0. Ecuador

Youtube Linkedin Facebook Instagram

Are you a
Health Professional?

Yes
No